ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity

References

• Kenchaiah S, Sesso HD, Gaziano JM. Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation 2009; 119:44-52; PMID:19103991; http://dx.doi.org/10.1161/CIRCULATIONAHA.108.807289.
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-13; PMID:12151467; http://dx.doi.org/10.1056/NEJMoa020245.
   PubMed Web of Science ®Google Scholar
• Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355:251-9; PMID:16855265; http://dx.doi.org/10.1056/NEJMoa052256.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013; 128:1810-52; PMID:23741057; http://dx.doi.org/10.1161/CIR.0b013e31829e8807.
   PubMed Web of Science ®Google Scholar
• Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity 2009; 17:625; author reply 6–7; PMID:19322142; http://dx.doi.org/10.1038/oby.2008.575.
   PubMed Web of Science ®Google Scholar
• Gaborit B, Venteclef N, Ancel P, Pelloux V, Gariboldi V, Leprince P, Amour J, Hatem SN, Jouve E, Dutour A, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res 2015; 108:62-73; PMID:26239655; http://dx.doi.org/10.1093/cvr/cvv208.
   PubMed Web of Science ®Google Scholar
• Doesch C, Haghi D, Fluchter S, Suselbeck T, Schoenberg SO, Michaely H, Borggrefe M, Papavassiliu T. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson 2010; 12:40; PMID:20624277; http://dx.doi.org/10.1186/1532-429X-12-40.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Kishino T, Sano J, Ariga T, Okuyama S, Mori H, Matsushima S, Ohtsuka K, Ohnishi H, Watanabe T. Relationship between epicardial adipose tissue thickness and early impairment of left ventricular systolic function in patients with preserved ejection fraction. Heart Vessels 2015. http://dx.doi.org/10.1007/s00380-015-0650-8.
   Web of Science ®Google Scholar
• Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275:33238-43; PMID:10924499; http://dx.doi.org/10.1074/jbc.M002615200.
   PubMed Web of Science ®Google Scholar
• Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res 2000; 87:E1-9; PMID:10969042; http://dx.doi.org/10.1161/01.RES.87.5.e1.
   PubMedGoogle Scholar
• Bader M, Alenina N, Andrade-Navarro MA, Santos RA. MAS and its related G protein-coupled receptors, Mrgprs. Pharmacol Rev 2014; 66:1080-105; PMID:25244929; http://dx.doi.org/10.1124/pr.113.008136.
   PubMed Web of Science ®Google Scholar
• Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35:807-25; PMID:12676168; http://dx.doi.org/10.1016/S1357-2725(02)00311-4.
   PubMed Web of Science ®Google Scholar
• Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86:747-803; PMID:16816138; http://dx.doi.org/10.1152/physrev.00036.2005.
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Quignard-Boulange A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 2011; 79:162-8; PMID:20944545; http://dx.doi.org/10.1038/ki.2010.391.
   PubMed Web of Science ®Google Scholar
• Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138:1512-9; PMID:9075710.
   PubMed Web of Science ®Google Scholar
• Boschmann M, Ringel J, Klaus S, Sharma AM. Metabolic and hemodynamic response of adipose tissue to angiotensin II. Obes Res 2001; 9:486-91; PMID:11500529; http://dx.doi.org/10.1038/oby.2001.63.
   PubMedGoogle Scholar
• Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 31:2856-64; PMID:21979434; http://dx.doi.org/10.1161/ATVBAHA.111.237198.
   PubMed Web of Science ®Google Scholar
• Zhang JD, Patel MB, Griffiths R, Dolber PC, Ruiz P, Sparks MA, Stegbauer J, Jin H, Gomez JA, Buckley AF, et al. Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis. J Clin Invest 2014; 124:2198-203; PMID:24743144; http://dx.doi.org/10.1172/JCI61368.
   PubMed Web of Science ®Google Scholar
• Souza LL, Costa-Neto CM. Angiotensin-(1–7) decreases LPS-induced inflammatory response in macrophages. J Cell Physiol 2012; 227:2117-22; PMID:21769868; http://dx.doi.org/10.1002/jcp.22940.
   PubMed Web of Science ®Google Scholar
• Thatcher SE, Gupte M, Hatch N, Cassis LA. Deficiency of ACE2 in Bone-Marrow-Derived cells increases expression of TNF-α in adipose stromal cells and augments glucose intolerance in obese C57BL/6 mice. Int J Hypertens 2012; 2012:762094; PMID:22518292; http://dx.doi.org/10.1155/2012/762094.
   PubMedGoogle Scholar
• Patel VB, Bodiga S, Basu R, Das SK, Wang W, Wang Z, Lo J, Grant MB, Zhong J, Kassiri Z, et al. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis. Circ Res 2012; 110:1322-35; PMID:22474255; http://dx.doi.org/10.1161/CIRCRESAHA.112.268029.
   PubMed Web of Science ®Google Scholar
• Patel VB, Bodiga S, Fan D, Das SK, Wang Z, Wang W, Basu R, Zhong J, Kassiri Z, Oudit GY. Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1–7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2-Null Mice. Hypertension 2012; 59:1195-203; PMID:22508831; http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.191650.
   PubMed Web of Science ®Google Scholar
• Patel VB, Parajuli N, Oudit GY. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clin Sci (Lond) 2014; 126:471-82; PMID:24329564; http://dx.doi.org/10.1042/CS20130344.
   PubMed Web of Science ®Google Scholar
• Patel VB, Takawale A, Ramprasath T, Das SK, Basu R, Grant MB, Hall DA, Kassiri Z, Oudit GY. Antagonism of angiotensin 1–7 prevents the therapeutic effects of recombinant human ACE2. J Mol Med (Berl) 2015; 93(9):1003-13.
   PubMed Web of Science ®Google Scholar
• Patel VB, Zhong JC, Fan D, Basu R, Morton JS, Parajuli N, McMurtry MS, Davidge ST, Kassiri Z, Oudit GY. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling. Hypertension 2014; 64:157-64; PMID:24799609; http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03388.
   PubMed Web of Science ®Google Scholar
• Wang W, Patel VB, Parajuli N, Fan D, Basu R, Wang Z, Ramprasath T, Kassiri Z, Penninger JM, Oudit GY. Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease. J Mol Med (Berl) 2014; 92:847-58; PMID:24728465; http://dx.doi.org/10.1007/s00109-014-1149-y.
   PubMed Web of Science ®Google Scholar
• Patel VB, Mori J, McLean BA, Basu R, Das SK, Ramprasath T, Parajuli N, Penninger JM, Grant MB, Lopaschuk GD, et al. ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity. Diabetes 2015; 65(1):85-95; http://dx.doi.org/10.2337/db15-0399.
   PubMed Web of Science ®Google Scholar
• Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y, Tsuneyama K, Nagai Y, Takatsu K, Urakaze M, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009; 58:2574-82; PMID:19690061; http://dx.doi.org/10.2337/db08-1475.
   PubMed Web of Science ®Google Scholar
• Cherian S, Lopaschuk GD, Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Endocrinol Metab 2012; 303:E937-49; PMID:22895783; http://dx.doi.org/10.1152/ajpendo.00061.2012.
   PubMed Web of Science ®Google Scholar
• Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444:875-80; PMID:17167476; http://dx.doi.org/10.1038/nature05487.
   PubMed Web of Science ®Google Scholar
• Fontes-Carvalho R, Fontes-Oliveira M, Sampaio F, Mancio J, Bettencourt N, Teixeira M, Rocha Gonçalves F, Gama V, Leite-Moreira A. Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction. Am J Cardiol 2014; 114:1663-9; PMID:25306552; http://dx.doi.org/10.1016/j.amjcard.2014.08.037.
   PubMed Web of Science ®Google Scholar
• Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc 2014; 3:e000582; PMID:24595191; http://dx.doi.org/10.1161/JAHA.113.000582.
   PubMedGoogle Scholar
• Loot AE, Roks AJ, Henning RH, Tio RA, Suurmeijer AJ, Boomsma F, van Gilst WH. Angiotensin-(1–7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002; 105:1548-50; PMID:11927520; http://dx.doi.org/10.1161/01.CIR.0000013847.07035.B9.
   PubMed Web of Science ®Google Scholar
• Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, et al. Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 2003; 100:8258-63; PMID:12829792; http://dx.doi.org/10.1073/pnas.1432869100.
   PubMed Web of Science ®Google Scholar
• Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, Fechner H, Schultheiss HP, Poller W. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J 2008; 29:1168-80; PMID:18390538; http://dx.doi.org/10.1093/eurheartj/ehn136.
   PubMed Web of Science ®Google Scholar
• Dadson K, Liu Y, Sweeney G. Adiponectin action: a combination of endocrine and autocrine/paracrine effects. Front Endocrinol 2011; 2:62; PMID:22649379; http://dx.doi.org/10.3389/fendo.2011.00062.
   PubMedGoogle Scholar
• Mori J, Patel VB, Ramprasath T, Alrob OA, DesAulniers J, Scholey JW, Lopaschuk GD, Oudit GY. Angiotensin 1–7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiol Renal Physiol 2014; 306:F812-21; PMID:24553436; http://dx.doi.org/10.1152/ajprenal.00655.2013.
   PubMedGoogle Scholar
• Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2:536-43; PMID:16186852; http://dx.doi.org/10.1038/ncpcardio0319.
   PubMedGoogle Scholar